Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.49 +0.00 (+0.04%)
As of: Sep 30, 2026 · 1:48 PM EDT

Pasithea Therapeutics (KTTA) Acquisitions (2022)

Updated

Pasithea Therapeutics' Acquisitions was $2.25 million in Q4 2022.

Analysis

Pasithea Therapeutics (KTTA) Acquisitions (2022) Analysis & Trends

For FY2022, Acquisitions at Pasithea Therapeutics came in at $2.19 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -17.24 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -23.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 11.21 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Pasithea Therapeutics 16.37 Mn 16.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 2.25 Mn
Sep 30, 2022 20,481.00
API Access

Pasithea Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=KTTA&period=max&api_key=YOUR_API_KEY